Amparo Santamaria

Has grant

Head of Department

HEALTH RIOJAN SERVICE

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Amparo Santamaria is the Head of Department at Ribera Salud SA in Spain. Her research focuses on the application of machine learning in medical settings, particularly in risk stratification for multiple myeloma and the use of innovative therapies for ovarian failure. She has contributed to studies on the safety and effectiveness of anticoagulants in atrial fibrillation and on minimally invasive techniques for assessing residual disease in patients. Her work also emphasizes the development of eHealth programs to improve clinical outcomes.

Recent Grants

Grant: Close

Couchmed

Open Date: 2025-01-01

Close Date: 2025-12-01

Grant: Close

Inteligencia artificial en aloanticuerpos

Open Date: 2025-01-01

Close Date: 2025-12-01

Grant: Close

Inteligencia artifical en gammapatías

Open Date: 2023-11-01

Close Date: 2024-05-01

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (1)

Arturo Gil

Profesor Titular de Universidad

Universidad Miguel Hernández de Elche

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amparo Santamaria

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Machine Learning-Based Predictive Model for Risk Stratification of Multiple Myeloma from Monoclonal Gammopathy of Undetermined Significance

Enhancing oocyte activation in women with ovarian failure: clinical outcomes of the Stem Cell Regenera study using G-CSF mobilization of peripheral blood stem cells and intraovarian injection of stem cell factor-enriched platelet rich plasma in real-world-practice

LOLATAO—An Artificial-Intelligence-Based Virtual Assistant for Clinical Follow-Up of Patients with Non-Valvular Atrial Fibrillation (AF) Undergoing Oral Anticoagulant Therapy (OAT): A Feasibility Study

Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.

Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.

Eligibility criteria for the use menopausal hormone therapy (MHT) in women with medical conditions (II): Endometriosis, neurological and autoimmune diseases

Safety and Effectiveness of Oral Anticoagulants in Atrial Fibrillation: Real-World Insights Using Natural Language Processing and Machine Learning.

P-803 Intra-ovarian injection of plasma rich in stem cell-secreted and platelet-enclosed factors to promote follicle rescue and reproductive outcomes in women with very low ovarian reserve

Development and Implementation of an eHealth Oncohematonootric Program: Descriptive, Observational, Prospective Cohort Pilot Study

Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program

Collaborators (1)

Arturo Gil

Make your next move.